NASDAQ : UFPT
UFP Technologies, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 284.5 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.20B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.20B |
| Enterprise Value | 2.33B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 7.75M |
| Shares Outstanding | 7.75M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 3.42% |
| Owned by Institutions (%) | 121.57% |
| Float | 7.48M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 30.76 |
| Forward PE | 28.56 |
| PS Ratio | 3.49 |
| Forward PS | 3.27 |
| PB Ratio | 4.77 |
| P/TBV Ratio | 16.86 |
| P/FCF Ratio | 35.88 |
| P/OCF Ratio | 30.79 |
| PEG Ratio | 1.90 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 32.24 |
| EV / Sales | 3.69 |
| EV / EBITDA | 20.11 |
| EV / EBIT | 24.23 |
| EV / FCF | 37.95 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.00 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | 2.22 |
| Interest Coverage | 12.38 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 17.05% |
| Return on Assets (ROA) | 9.13% |
| Return on Invested Capital (ROIC) | 13.47% |
| Return on Capital Employed (ROCE) | 15.94% |
| Weighted Average Cost of Capital (WACC) | 9.62% |
| Revenue Per Employee | $130,342 |
| Profits Per Employee | $14,918 |
| Employee Count | 4,846 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 4.88 |
Taxes
| Measure | Value |
|---|
| Income Tax | 16.35M |
| Effective Tax Rate | 18.44% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +47.69% |
| 50-Day Moving Average | 291.24 |
| 200-Day Moving Average | 249.39 |
| Relative Strength Index (RSI) | 44.04 |
| Average Volume (20 Days) | 96,071 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 980,950 |
| Short Previous Month | 1.04M |
| Short % of Shares Out | 12.66% |
| Short % of Float | 13.12% |
| Short Ratio (days to cover) | 8.62 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 631.64M |
| Gross Profit | 180.00M |
| Operating Income | 96.19M |
| Pretax Income | 88.64M |
| Net Income | 72.30M |
| EBITDA | 115.91M |
| EBIT | 96.19M |
| Earnings Per Share (EPS) | $9.25 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.05M |
| Total Debt | 136.34M |
| Net Cash | -127.29M |
| Net Cash Per Share | -$16.43 |
| Equity (Book Value) | 462.43M |
| Book Value Per Share | 59.70 |
| Working Capital | 156.59M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 71.58M |
| Capital Expenditures | -10.16M |
| Depreciation & Amortization | 19.72M |
| Net Borrowing | -46.37M |
| Free Cash Flow | 61.42M |
| FCF Per Share | $7.93 |
Margins
| Measure | Value |
|---|
| Gross Margin | 28.50% |
| Operating Margin | 15.23% |
| Pretax Margin | 14.03% |
| Profit Margin | 11.45% |
| EBITDA Margin | 18.35% |
| EBIT Margin | 15.23% |
| FCF Margin | 9.72% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
| Earnings Yield | 3.25% |
| FCF Yield | 2.79% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $355.00 |
| Price Target Difference | 24.78% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 7.53% |
| EPS Growth Forecast (3Y) | 12.10% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 7.17 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |